S. Cheng

发表

Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov.

Amy P Abernethy, Karen Chiswell, Robert M Califf, 2013, JAMA internal medicine.

The impact of delay: Assessing the early indicators of development time and accrual milestones on oncology clinical trial success

S. Cheng, 2008 .

Predicting Accrual Achievement: Monitoring Accrual Milestones of NCI-CTEP–Sponsored Clinical Trials

Mary S Dietrich, David M Dilts, D. Dilts, 2011, Clinical Cancer Research.

Therapy Evaluation Program ( NCI-CTEP ) Sponsored Studies Development Time and the Accrual Performance of Cancer A Sense of Urgency : Evaluating the Link between Clinical Trial

D. Dilts, M. Dietrich, S. Cheng, 2010 .

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.

David M. Dilts, Steven K. Cheng, Shanda Finnigan, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biomarker testing and tissue journey among patients with metastatic non-small cell lung cancer receiving first-line therapy in the US Oncology Network biomarker testing in metastatic NSCLC with first-line therapy.

N. Robert, R. Coleman, M. Karhade, 2022, Lung cancer.

A Sense of Urgency: Evaluating the Link between Clinical Trial Development Time and the Accrual Performance of Cancer Therapy Evaluation Program (NCI-CTEP) Sponsored Studies

D. Dilts, M. Dietrich, S. Cheng, 2010, Clinical Cancer Research.

Early indicators of accrual success: Time-to-first-patient and accrual performance at an anticipated enrollment milestone-A study of NCI-CTEP-sponsored clinical trials.

D. Dilts, M. Dietrich, S. Cheng, 2010 .

The Prevalence and Economic Impact of Low-Enrolling Clinical Studies at an Academic Medical Center

D. Dilts, E. Orwoll, S. Cheng, 2011, Academic medicine : journal of the Association of American Medical Colleges.

Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

Richard L Schilsky, David M Dilts, Stephen L George, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accrual to clinical trials at selected comprehensive cancer centers

D. Dilts, M. Bookman, A. Sandler, 2008 .

Phase III Clinical Trial Development: A Process of Chutes and Ladders

James H. Doroshow, David M. Dilts, Steven K. Cheng, 2010, Clinical Cancer Research.

tes and Ladders

J. Doroshow, A. Sandler, S. Cheng, 2010 .

Development of Clinical Trials in a Cooperative Group Setting: The Eastern Cooperative Oncology Group

Robert Gray, Donna Marinucci, David M Dilts, 2008, Clinical Cancer Research.

The Importance of Doing Trials Right While Doing the Right Trials

D. Dilts, S. Cheng, 2011, Clinical Cancer Research.

A Sense of Urgency: Evaluating the Link between Clinical Trial Development Time and the Accrual Performance of Cancer Therapy Evaluation Program (NCI-CTEP) Sponsored Studies

D. Dilts, M. Dietrich, S. Cheng, 2010, Clinical Cancer Research.

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.

M. Mooney, J. Abrams, D. Dilts, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Building Expertise in Translational Processes through Partnerships with Schools of Business

David M. Dilts, Steven K. Cheng, D. Dilts, 2013 .